Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01563887 · ClinicalTrials.gov registry record · NA

Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)

A NA study of Type 1 Diabetes and Hypoglycemia, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
568
Enrollment target
1
Study location

NCT01563887 is a NA study of Type 1 Diabetes and Hypoglycemia that has completed, run by University of Virginia. The registered enrollment target is 568 participants, below the 821-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01563887, a NA study of Type 1 Diabetes and Hypoglycemia, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
568 participants
Enrollment target
1
Study location

Study Summary

This study will recruit drivers with Type 1 diabetes from across the U.S. and assign them to four groups based on their presumed risk level- routine care low risk, routine care high risk, or to one of two Internet interventions focused on reducing hypoglycemia driving. All subjects will be followed for two years to determine whether and which intervention was most effective at reducing hypoglycemia related driving collisions.

Interventions

  • BEHAVIORAL DD.com
  • BEHAVIORAL DD.com + MI

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 568 participants
Start Date 2012-02
Est. Completion 2014-10
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT01563887

The ClinicalTrials.gov registry entry for NCT01563887 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 568 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 821-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (31% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which DD.com is the first listed.

NCT01563887 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT01563887 about?

NCT01563887 is a clinical study titled "Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving.Com)". This study will recruit drivers with Type 1 diabetes from across the U.S. and assign them to four groups based on their presumed risk level- routine care low risk, routine care high risk, or to one of two Internet interventions focused on reducing hypoglycemia driving. All subjects will be followed ...

What is the current status of trial NCT01563887?

This trial is currently completed. It is a NA study. The enrollment target is 568 participants. The study started on 2012-02. Estimated completion is 2014-10.

What conditions does trial NCT01563887 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Hypoglycemia.

What interventions are being tested in trial NCT01563887?

The interventions under investigation include: DD.com (BEHAVIORAL), DD.com + MI (BEHAVIORAL).

Who is sponsoring clinical trial NCT01563887?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01563887 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.